Evaluating the Efficacy and Safety of Embella (Deoxycholic Acid, Produced by Espad Pharmed Co.) Injection in the Management of Superficial Lipomas
Clinical trial NCT07014163 · RECRUITING
Trial details
- NCT number
- NCT07014163
- Sponsor
- Espad Pharmed
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2026-03-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.